IFG
NEPH icon

Independent Financial Group’s Nephros NEPH Stock Holding History

Independent Financial Group’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,000
Closed -$25.3K – 1175
2024
Q2 		$25.3K Buy
+12,000
New +$25.9K ﹤0.01% 1078

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Independent Financial Group's NEPH Position: Q3 2024 in Review

Independent Financial Group sold out of Nephros (NEPH) in Q3 2024, closing a stake of 12,000 shares — an estimated $25.3K sold.

Independent Financial Group first reported a position in NEPH in Q2 2024 and held it in 1 quarter. The position peaked at $25.3K in Q2 2024. 17 funds tracked by Wall St. Rank hold NEPH as of Q3 2024.

  • Independent Financial Group reported no remaining Nephros position as of Q3 2024 after selling out during the quarter.
  • Independent Financial Group sold 12,000 Nephros shares in Q3 2024, an estimated $25.3K.
  • Independent Financial Group first reported a position in Nephros in Q2 2024 and held it in 1 quarter.
  • Independent Financial Group's Nephros position peaked at $25.3K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held Nephros as of Q3 2024.

Based on Independent Financial Group's 13F filing for Q3 2024, filed 12 Jun 2026.